classification system.Beta-blockers constitute class 2 agents in the VW classification. [2]Nebivolol is a cardio-selective betablocker with additional endothelium-dependent vasodilating activity that stimulates nitric oxide (NO) synthesis, resulting in NO-mediated vasodilation.Considering its positive effects on cardiac pathologies, nebivolol can be involved in both direct and indirect treatment of rhythm disorders. [3] this article, the role of autonomic nerve activity in arrhythmias, the molecular mechanisms of action, and the pharmacological properties of Beta-Adrenergic Blockers, as AbstractBeta-blockers are commonly used medications for cardiovascular diseases.Beta-blockers are effective antiarrhythmic agents, and they are class 2 agents in the Vaughan-Williams classification.In this review, we first attempt to mention the physiology of beta-adrenergic activation in the myocardium and the role of excessive beta-adrenergic activation in arrythmiagenesis.Then, we will summarize the pharmacological properties of beta blockers and their use in specific arrhythmias.Special emphasis will be given to nebivolol, a new generation cardioselective beta-blocker with vasodilator activity, given the limited data regarding its use in arrhythmias.
No takes yet. Share an insight, caveat, or question.
Görenek et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: